Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Report 2026

Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Overview

• Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing market size has reached to $1.34 billion in 2025 • Expected to grow to $3.18 billion in 2030 at a compound annual growth rate (CAGR) of 18.9% • Growth Driver: Surge In Precision Medicine Adoption Fueling The Growth Of Market Due To Growth Amid Rising Need For Targeted Therapies • Market Trend: Advancements In High-Fidelity Single-Molecule Sequencing Platforms Drive RNA Research Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market?

Long-read full-length complementary DNA (cDNA) sequencing is a technique that captures and sequences complete complementary DNA (cDNA) molecules derived from RNA transcripts, preserving their full-length structure. It provides a comprehensive view of transcriptomes, allowing precise characterization of complex RNA molecules. The main technologies of long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing include Pacific Biosciences single-molecule real-time (PacBio SMRT), oxford nanopore, and other technologies. Pacific Biosciences single-molecule real-time (PacBio SMRT) is a sequencing technology that enables highly accurate, long-read sequencing of full-length cDNA molecules for comprehensive transcriptome analysis. The product types include instruments and sequencing platforms, reagents and consumables, library preparation kits, flow cells and chips, and data analysis software and bioinformatics tools and the sample types include human, animal, plant, and microbial. They find application in transcriptome analysis, gene expression studies, alternative splicing detection, fusion gene detection, and other applications, serving end users including academic and research institutes, pharmaceutical and biotechnology companies, clinical laboratories, and other end users.

What Is The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Growth Forecast?

The long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market size is expected to see rapid growth in the next few years. It will grow to $3.18 billion in 2030 at a compound annual growth rate (CAGR) of 18.9%. The growth in the forecast period can be attributed to growing demand for precision medicine applications, increasing integration of AI-driven bioinformatics tools, rising use in rare disease research, expansion of clinical transcriptomics, development of cost-efficient long-read sequencing workflows. Major trends in the forecast period include increasing adoption of single-cell full-length cDNA Sequencing, rising demand for high-fidelity long-read platforms, growing use in alternative splicing detection, expansion of transcript isoform characterization studies, rising integration of advanced library preparation kits.

Global Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Segmentation

1) By Technology: Pacific Biosciences Single-Molecule Real-Time (PacBio SMRT), Oxford Nanopore, Other Technologies 2) By Product Type: Instruments And Sequencing Platforms, Reagents And Consumables, Library Preparation Kits, Flow Cells And Chips, Data Analysis Software And Bioinformatics Tools 3) By Sample Type: Human, Animal, Plant, Microbial 4) By Application: Transcriptome Analysis, Gene Expression Studies, Alternative Splicing Detection, Fusion Gene Detection, Other Application 5) By End-Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End Users Subsegments: 1) By Pacific Biosciences Single-Molecule Real-Time (PacBio SMRT): Sequel System, Sequel II System, RS II System, High-Fidelity Sequencing Systems 2) By Oxford Nanopore: MinION Sequencing Devices, GridION Sequencing Platforms, PromethION Sequencing Platforms, Flongle Sequencing Modules 3) By Other Technologies: Synthetic Long-Read Sequencing, Linked-Read Sequencing, Single-Cell Full-Length cDNA Sequencing, Hybrid Sequencing Approaches

What Is The Driver Of The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market?

The growing focus on precision medicine is expected to propel the growth of the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market going forward. Precision medicine is a healthcare approach that customizes prevention and treatment according to an individual’s genetic and molecular characteristics. The focus on precision medicine is increasing due to the rising need for effective therapies for heterogeneous and treatment-resistant diseases. Long-read full-length cDNA sequencing enhances clinical decision-making by providing comprehensive insights into transcript isoforms and actionable biomarkers, enabling more precise selection of targeted therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. Therefore, the growing focus on precision medicine is driving the growth of the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing industry.

Key Players In The Global Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market

Major companies operating in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market are Eurofins Scientific SE, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., Azenta Life Sciences Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Macrogen Inc., DNAnexus Inc., Zymo Research Corporation, CD Genomics Inc., BaseClear B.V., Microsynth AG, Creative Biogene Inc., Nucleome Informatics Inc., Operify Tech Pvt. Ltd., Signios Bio Inc.

Global Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Trends and Insights

Major companies operating in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market are focusing on developing innovative solutions, such as high-fidelity single-molecule sequencing platforms, to improve transcript accuracy and detect complex RNA isoforms. High-fidelity single-molecule sequencing platforms, which read entire cDNA molecules with low error rates without fragmentation, help accurately capture full-length transcripts and detect complex RNA isoforms in a single run. For instance, in December 2023, Pacific Biosciences of California Inc., a US-based biotechnology company, launched Kinnex RNA kits designed to enhance RNA research. It leverages high-fidelity single-molecule sequencing platforms technology combined with optimized library preparation workflows to produce highly accurate, long-read transcriptome data. Its unique features include ultra-long reads spanning entire transcripts, high consensus accuracy, and compatibility with complex RNA samples, enabling researchers to detect alternative splicing, fusion transcripts, and novel isoforms with unprecedented precision. Kinex finds applications in genomics, transcriptomics, biomarker discovery, and therapeutic target identification, offering a more comprehensive view of RNA biology compared to conventional methods.

What Are Latest Mergers And Acquisitions In The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market?

In February 2026, ArgenTag, a US-based biotechnology company, partnered with Pacific Biosciences of California Inc. (PacBio) to advance long-read single-cell transcriptomics capabilities. With this partnership, Argenta Genomics Inc. and Pacific Biosciences of California, Inc. aim to integrate PacBio’s highly accurate long-read sequencing platforms with Argenta’s single-cell analysis methods to enable deeper and more comprehensive profiling of cellular transcriptomes, improving the discovery and characterization of complex biological processes. Pacific Biosciences of California, Inc. is a US-based company specializing in long-read DNA sequencing technology for genomics research and clinical applications.

Regional Insights

North America was the largest region in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market?

The long-read full-length complementary DNA (cDNA) sequencing market consists of revenues earned by entities by providing services such as full-length transcript sequencing, isoform identification, alternative splicing analysis, gene expression profiling, and RNA modification detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The long-read full-length cDNA sequencing market also includes sales of RNA extraction kits, quality control tools, and specialized reagents, and nucleic acid quantification kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Report 2026?

The long-read full-length complementary deoxyribonucleic acid (cdna) sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the long-read full-length complementary deoxyribonucleic acid (cdna) sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.